PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN SPANISH PATIENTS WITH HEPATOCELLULAR CARCINOMA AND HEPATIC CIRRHOSIS-Reference-Cited by-同舟云学术

PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN SPANISH PATIENTS WITH HEPATOCELLULAR CARCINOMA AND HEPATIC CIRRHOSIS

Published:1989-10 Issue:8670 Volume:334 Page:1004-1006
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Bruix Jordi,Calvet Xavier,Costa Josep,Ventura Miquel,Bruguera Miquel,Castillo Ricard,María Barrera Josep,Ercilla Guadalupe,María Sanchez-Tapias José,Vall Marti,Bru Concepciò,Rodes Joan

Publisher

Elsevier BV

Subject

General Medicine

Reference17 articles.

1. Epidemiology of hepatocellular carcinoma;Muñoz,1987

2. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma. Epidemiologic considerations;Beasley;Hepatology,1982

3. A case control study of primary hepatocellular carcinoma in Taiwan;Lu;Cancer,1988

4. The development of hepatocellular cancer in humans;Kew;Cancer Surv,1986

5. Cirrhosis and the aetiology of hepatocellular carcinoma;Johnson;J Hepatol,1987

Cited by 544 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis Viruses: Hepatocellular Carcinoma;Viral Infections of Humans;2023

2. Breakthroughs in hepatitis C research: from discovery to cure;Nature Reviews Gastroenterology & Hepatology;2022-05-20

3. Effect of cirrhosis and hepatitis on the prognosis of liver cancer;Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma;2022

4. Risk Factors for Hepatocellular Carcinoma: A Historical Perspective;Clinical Liver Disease;2021-10

5. Adherence to clinical follow-up recommendations for liver function tests: A cross-sectional study of patients with HCV and their associated risk behaviors;Preventive Medicine Reports;2021-09